Clinical trial Recruiting at 6 sites Observational Ages 18 to 29

Care for young adults with relapsing-remitting MS

Official title: CARE in MS: Childhood Adversity Research Effort in MS

Run by NYU Langone Health · NCT07011914 · Data updated 2026-11-12

This project will test culturally tailored ways to measure childhood adversity and see if past adversity links to blood, MRI, and quality-of-life outcomes in young adults with relapsing-remitting MS, prioritizing Black, Hispanic, and low-income participants.

Quick facts

Study typeObservational
Ages18 Years to 29 Years
SexAll
Enrollment300 (estimated)
SponsorNYU Langone Health
Academic / other
Locations6 sites (Birmingham, Alabama and 5 other locations)
StatusRecruiting
StartedOctober 23, 2025
Main results expectedJune 30, 2029
Study endsJune 30, 2029
Registry record updatedOctober 26, 2026
Trial IDNCT07011914 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 18–29-year-olds with relapsing-remitting MS who can read English or Spanish, with an emphasis on those who self-identify as Black, Hispanic, or are low-income and who meet the study's onset and disease-duration windows.

Probably not a fit

Older adults, people with progressive forms of MS, non-English/Spanish speakers, or those with disease duration beyond the study limits are unlikely to gain direct benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project uses community-based participatory research to develop culturally tailored measures of childhood adversity for people with MS. In a cross-sectional arm, eligible young adults with relapsing-remitting MS will attend two visits including a research blood draw and MRI to examine relationships between adversity and clinical, imaging, and laboratory outcomes. A subset of participants will complete interviews and surveys to explore environmental and social factors that affect quality of life among minority and underrepresented MS patients. The work is conducted across multiple U.S. academic sites with involvement from a federal neurological institute.

Why it matters

Potential benefit: If successful, this work could lead to culturally appropriate screening for childhood adversity and more targeted supports that improve outcomes and quality of life for young adults with RRMS.

How similar studies have gone: Previous research has linked childhood adversity to worse MS outcomes, but applying community-based, culturally tailored measurement methods in a young, underrepresented RRMS population is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Aim 1 -

* aged ≥18-29 years
* diagnosis of RRMS (Fulfill international criteria for relapsing remitting (RRMS))
* 70% self-identifying as a Black, Hispanic, or poverty-impacted (up to 138% of the federal poverty level) individual,and
* fluent in English or Spanish.

Aim 2 -

* aged ≥18-29 years
* diagnosis of RRMS (Fulfill international criteria for relapsing remitting (RRMS))
* 70% self-identifying as a Black, Hispanic, or poverty impacted, and
* fluent reading in English or Spanish
* Pediatric onset MS (MS onset before age 18 and age at time of enrollment is 18-25) OR adult-onset MS (MS onset at age 18 or older and age at time of enrollment is 19-29)
* Disease duration below 8 years

Aim 3 -

Aim 3 will enroll the first 20 participants from Aim 2 who meet the following criteria:

* completed at least 80% of study data in the cross-sectional study/Aim 2.
* a total of 70% must self-identify as Black, Hispanic, or meet criteria for poverty impacted.
* interviews will be evenly split between participants with high (top quartile) and low (bottom quartile) of PROMIS-10 scores.

Exclusion Criteria:

* Primary or Secondary Progressive MS
* Inability to consent.
* MS relapse within 30 days prior to study entry
* Other major neurologic or psychiatric illness

Where it's running

  • University of Alabama at Birmingham
    Birmingham, Alabama, United States
    Recruiting
  • University of California, San Francisco
    San Francisco, California, United States
    Recruiting
  • University of Colorado Denver
    Aurora, Colorado, United States
    Recruiting
  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting
  • Baylor College of Medicine
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.